Stat3 induces oncogenic Skp2 expression in human cervical carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 418, Issue 1, 2012, Pages 186-190

  Huang, Hanhui ^a   Zhao, Wenrong ^b   Yang, Dan ^c  

^a FUDAN UNIVERSITY   (China)

^b OBSTETRICS AND GYNECOLOGY HOSPITAL OF FUDAN UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Cervical carcinoma; Protein degradation; Skp2; Stat3

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; PROTEIN P27; PROTEIN P300; S PHASE KINASE ASSOCIATED PROTEIN 2; STAT3 PROTEIN;

ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL PROLIFERATION; CELL STRAIN HEK293; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; RNA TRANSCRIPTION; UTERINE CERVIX CARCINOMA;

CARCINOMA; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HEK293 CELLS; HELA CELLS; HUMANS; INTERLEUKIN-6; LUCIFERASES; ONCOGENES; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN STABILITY; S-PHASE KINASE-ASSOCIATED PROTEINS; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84862809754     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.004     Document Type: Article

References (24)

1. Amati B., Vlach J. Kip1 meets SKP2: new links in cell-cycle control. Nat. Cell Biol. 1999, 1:E91-E93.
2. Cardozo T., Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 2004, 5:739-751.
3. Nakayama K.I., Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 2005, 16:323-333.
4. Carrano A.C., Eytan E., Hershko A., Pagano M. SKP2 is required for ubiqui-tin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1999, 1:193-199.
5. Tsvetkov L.M., Yeh K.H., Lee S.J., Sun H., Zhang H. p27 Kip1 ubiquitination and degradation is regulated by the SCF Skp2 complex through phosphorylated Thr187 in p27. Curr. Biol. 1999, 9:661-664.
6. Huang T., Tindall D.J. Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochim. Biophys. Acta. 2011, 11:1961-1964.
7. Kitagawa K., Kotake Y., Kitagawa M. Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci. 2009, 8:1374-1381.
8. Andreu E.J., et al. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27 Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Cancer Res. 2005, 65:3264-3272.
9. van Duijn P.W., Trapman J. PI3K/Akt signaling regulates p27 kip1 expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27 kip1 regulation in LNCaP and PC346 cells. Prostate 2006, 66:749-760.
10. Signoretti S., et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J. Clin. Invest. 2002, 110:633-641.
11. Bloom J., Pagano M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 2003, 13:41-47.
12. Yu H., Jove R. The STATs of cancer-new molecular targets come of age. Nat. Rev. Cancer 2004, 4:97-105.
13. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009, 9:798-809.
14. Yu H., Kortylewski M., Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 2007, 7:41-51.
15. Lee H., et al. Persistently activated Stat3 maintains constitutive NF-κB activity in tumors. Cancer Cell 2009, 15:283-293.
16. Lee J.L., Wang M.J., Chen J.Y. Acetylation and activation of Stat3 by nuclear translocation of CD44. J. Cell Biol. 2009, 6:949-957.
17. Reichert M., Saur D., Hamacher R., Schmid R.M., Schneider G. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. Cancer Res. 2007, 67:4149-4156.
18. Barre B., Perkins N.D. A cell cycle regulatory network controlling NF-κB subunit activity and function. EMBO J. 2007, 26:4841-4855.
19. Mamillapalli R., Gavrilova N., Mihaylova V.T., et al. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr Biol. 2001, 11:263-267.
20. Bretones G., Acosta J.C., Caraballo J.M., Ferrándiz N., et al. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells. J. Biol. Chem. 2001, 11:9815-9825.
21. Catlett-Falcone R., et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999, 10:105-115.
22. Shukla S., Shishodia G., Mahata S., et al. Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Mol. Cancer 2010, 27:282.
23. Wang K., Zhou B., Zhang J., Xin Y., et al. Association of signal transducer and activator of transcription 3 gene polymorphisms with cervical cancer in Chinese women. DNA Cell Biol. 2011, 11:931-936.
24. Faridi R., Zahra A., Khan K., Idrees M. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol J. 2011, 3:269.